UBS Group AG

Holdings History for Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC)

Symbol: ORIC on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$6,011,138	734,858	+395,622	+117%	$8.18	Q4 2025
30 Sep 2025	0%	+0%	$4,070,832	339,236	+240,230	+243%	$12.00	Q3 2025
30 Jun 2025	0%	+0%	$1,004,911	99,006	+19,468	+24%	$10.15	Q2 2025
31 Mar 2025	0%	+0%	$443,822	79,538	+4,609		$5.58	Q1 2025
31 Dec 2024	0%	+0%	$604,677	74,929	+3,374	+4.7%	$8.07	Q4 2024
30 Sep 2024	0%	-0%	$733,440	71,555	-9,252	-11%	$10.25	Q3 2024
30 Jun 2024	0%	-0%	$571,305	80,807	-13,254	-14%	$7.07	Q2 2024
31 Mar 2024	0%	+0%	$1,293,339	94,061	+53,088	+130%	$13.75	Q1 2024
31 Dec 2023	0%	+0%	$376,952	40,973	+23,701	+137%	$9.20	Q4 2023
30 Sep 2023	0%	-0%	$104,496	17,272	-4,996	-22%	$6.05	Q3 2023
30 Jun 2023	0%	+0%	$172,800	22,268	+22,268	NEW	$7.76	Q2 2023
31 Mar 2023		-0%	$0	0	-4,433	-100%	$10.42	Q1 2023
31 Dec 2022	0%	+0%	$26,110	4,433	+4,433	NEW	$5.89	Q4 2022
30 Sep 2022		-0%	$0	0	-2,204	-100%	$10.42	Q3 2022
30 Jun 2022	0%	+0%	$10,000	2,204	+2,204	NEW	$4.54	Q2 2022
31 Mar 2022		-0%	$0	0	-62,399	-100%	$10.42	Q1 2022
31 Dec 2021	0%	+0%	$917,000	62,399	+36,413	+140%	$14.70	Q4 2021
30 Sep 2021	0%	+0%	$544,000	25,986	+18,747	+259%	$20.93	Q3 2021
30 Jun 2021	0%	-0%	$128,000	7,239	-24,265	-77%	$17.68	Q2 2021
31 Mar 2021	0%	+0%	$772,000	31,504	+29,977	+1963%	$24.50	Q1 2021
31 Dec 2020	0%	-0%	$52,000	1,527	-83	-5.2%	$34.05	Q4 2020
30 Sep 2020	0%	-0%	$40,000	1,610	-1,234	-43%	$24.84	Q3 2020
30 Jun 2020	0%	+0%	$96,000	2,844	+2,844	NEW	$33.76	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.